LONDON (AP) – Pfizer Inc. և BioNTech have petitioned the European Drug Regulatory Authority to approve their coronavirus vaccine to be distributed to children aged 12 to 15, which may be offered to a younger, lower-risk group. : This is the first time in Europe that people have been shot.
In a statement on Friday, the two pharmaceutical companies said their submission to the European Medicines Agency was based on a study of more than 2,000 adolescents that showed their vaccines were safe and effective. The children will be back for two more years for longer protection and safety.
BioNTech և Pfizer has previously applied for their emergency use with the US Food and Drug Administration to extend it to children ages 12 to 15.
German Health Minister Jens Span has welcomed the news that the vaccine could soon be given the green light for older children.
“It could make a real difference in our vaccine campaign if it is approved,” he said during a visit to a vaccine factory in the German city of Rheinbeck.
Pfizer CO The COVID-19 vaccine, developed by BioNTech, was the first to receive the green light from the EMA last December, when it was patented in all 27 EU countries over the age of 16.
– Follow AP epidemic coverage at https://apnews.com/hub/coronavirus-pandemic և https://apnews.com/hub/coronavirus-vaccine